WOLVERINE ASSET MANAGEMENT LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$52,000
-38.8%
5,114
-29.2%
0.00%
-50.0%
Q3 2015$85,000
-22.7%
7,220
-2.8%
0.00%0.0%
Q2 2015$110,000
+3566.7%
7,430
+52971.4%
0.00%
Q1 2015$3,0000.0%140.0%0.00%
Q4 2014$3,000
-98.1%
14
-99.8%
0.00%
-100.0%
Q3 2014$160,000
-9.6%
6,3250.0%0.00%
-25.0%
Q2 2014$177,0006,3250.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders